Hypertension Clinical Trials

Showing 2661-2680 of 3,009 trials

Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage

NCT01533584

The aim of this study is to evaluate nocturnal hypertension with 24-hour ambulatory blood pressure and home blood pressure (BP) measurements through a) comparison of mean BP and nocturnal dipping assessed with the two methods, b) correlation of those parameters with parameters of target-organ damage and c) comparison of the potential of the two methods to define non-dippers.

Nocturnal Hypertension

University of Athens100 participantsStarted Mar 2012

Athens, Greece • Athens, Greece

COMPLETED

NTX Wireless Patient Monitoring System

NCT00654693

* Determine the accuracy of the NTX wireless monitoring system alerts * Evaluate patient compliance with wearing device * Determine false alarm rates

DesaturationBradycardiaTachycardia+2 more

Vanderbilt University26 participantsStarted Mar 2008

Nashville, Tennessee, United States

COMPLETEDPhase 2

ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects

NCT01668524

This single-site, dose-escalation study will evaluate safety and tolerability of increasing concentrations of ATS907 in 12 subjects with Primary Open Angle Glaucoma and/or Ocular Hypertension

Primary Open Angle GlaucomaOcular Hypertension

Altheos, Inc.12 participantsStarted Aug 2012

Artesia, California, United States

COMPLETEDPhase 3

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

NCT01135212

The purpose of this clinical study is to evaluate and compare the efficacy and safety of Fimasartan (60mg / 120mg) with Candesartan(8mg) in patients with mild to moderate hypertension.

Hypertension

Boryung Pharmaceutical Co., Ltd290 participantsStarted Apr 2010

Daegu, Daegu, South Korea

Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage

NTX Wireless Patient Monitoring System

ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

Related Searches

Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)

Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb

Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Assessing Outcome After H-graft Shunt Placement

Inflammatory Response to Salt in Essential Hypertension

Clinical Study of Wrist Blood Pressure Monitor in Conformance With the ANSI/AAMI SP10 Standard

Additive Effects of Pravastatin and Valsartan

Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)

24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension

Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy in Pulmonary Arterial Hypertension (ATHENA-1)

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure

Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost

1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT

Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension